AI in Medical Imaging Market to Surge to USD 28.91B by 2034

The global Artificial Intelligence (AI) in Medical Imaging market is poised for significant growth, with a projected value of USD 28.91 billion by 2034, marking a compound annual growth rate (CAGR) of 35.3% over the forecast period. This expansion is driven by the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions, which necessitates early detection and precision diagnosis. According to the World Health Organization, noncommunicable diseases account for 74% of global deaths annually.

The market's base year value stood at USD 1.89 billion in 2025, and it is projected to reach USD 28.91 billion by 2034, reflecting a CAGR of 35.3% from 2026 to 2034. North America leads the market with a 41.2% revenue share in 2025, with the United States contributing 59.22% of the regional market. This region's growth is bolstered by advanced healthcare infrastructure, early adoption of AI technologies, strong research and development (R&D) investment, and supportive FDA initiatives for AI-based medical devices.

In contrast, the Asia Pacific region is forecast to post the fastest growth, with a CAGR of 38.6% over the study period. This growth is attributed to expanding healthcare sectors and rising investments in AI technologies in countries such as China, Japan, and India. Europe, which held a 28.6% share in 2025, is supported by rising adoption of digital pathology and government funding, with Germany, the United Kingdom, and France at the forefront.

The market is moderately consolidated, with imaging-equipment leaders such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems embedding AI directly into their hardware. AI-native specialists and a steady stream of start-ups are also present, alongside technology companies like Microsoft and NVIDIA providing the foundation models, compute, and cloud platforms that imaging AI runs on. Competition centers on diagnostic performance and workflow integration, and strict healthcare regulations can limit the entry of new players. Companies are pursuing partnerships with healthcare providers, cloud-based offerings, and acquisitions to defend and grow their positions.

The market is expected to be segmented by technology, deployment mode, application, modalities, and end use. Cloud-based and federated AI imaging platforms represent a significant growth area, offering hospitals the flexibility to adopt AI without heavy capital expenditure on infrastructure. Portable, affordable AI-enabled imaging devices also hold promise in emerging markets and in rural and underserved areas, with vendors that combine scalable cloud-based offerings with niche applications such as early disease detection standing to differentiate themselves as the market matures.

In addition to these market insights, the release also highlights the U.S. Rockets and Missiles market, which is projected to reach USD 37.19 billion by 2034 at a CAGR of 5.62% across the forecast window. The Fintech as a Service (FaaS) market is expected to touch USD 1,590.75 billion by 2034 at a CAGR of 14.5%, and the Electric Commercial Vehicle Market is forecast to reach USD 211.54 billion by 2034 at a CAGR of 12.10%. These markets are driven by various factors, including defense modernization, financial infrastructure, and technological advancements, respectively.